Article

China Daily update: Harvard genetic research in rural China Wed, 1 Oct 2003 “It’s the responsibility of the dean of the School of Public Health and, ultimately, it’s my responsibility as president of [Harvard] university to see to it that where wrong can be put right it is and, more…

AHRP Comments – Precursors to Diabetes in Japanese American Youth

ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) August 21, 2002 Comments Re: DHHS Notice of Proposed Recommendation Regarding Support of Research Protocol: "Precursors to Diabetes in Japanese American Youth" Grant Number I R01 DK59234-01 The proposed experiment would involve 450 children healthy children, aged 8-10 years old, 300 of Japanese ancestry…

DHHS Reverses its Legal Position Petitioning FOR Whistleblower Protection for Dr. Fishbein

DHHS Reverses its Legal Position Petitioning FOR Federal Whistleblower Protection for Dr. Fishbein Thu, 3 Feb 2005 The Washington Post reports: “Department of Health and Human Services filed a legal petition this week in support of an employee the department is trying to fire. HHS told the Merit Systems Protection…

Infomail Archive 2005

Infomail 2005 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Subscribe to the AHRP infomail list Dec 16: Drugs, Devices & Doctors – NYT Paul Krugman Dec 11: Scientific Fraud & Corruption on Both sides of Atlantic: Merck / Proctor & Gamble Dec 11: Gov Accountability…

DHHS Report: Contradicting itself on drug imports – OpEd Peter Rost

DHHS Report: Contradicting itself on drug imports – OpEd Peter Rost Wed, 5 Jan 2005 Dr. Peter Rost, a Pfizer Vice-President of Marketing knows about the financial underpinnings of drug pricing. He has taken a consciencious public position (unsusual in that industry) because he believes the American public has a…

AHRP Files Federal Complaint Re: Non-Consensual “Blood Substitute” Experiment on Trauma Patients

This controversial, commercial experiment is being conducted without informed consent in trauma patients who require blood to survive.  PolyHeme is being tested in patients in ambulances and at hospital emergency facilities where these trauma patients are denied life-saving real blood.